Since 2001, Mike Simpson has been a group leader for the Nanofabrication Research Laboratory and theme leader in the Center for Nanophase Materials Sciences. His research focus includes noise biology, nano-enabled synthetic biology and controlled synthesis and directed assembly of carbon nanostructures.
Filter Corporate Fellows
Corporate Fellow Type
Year
- (-) 2014 (1)
- (-) 2013 (2)
- (-) 2005 (3)
- (-) 2000 (1)
- (-) 1996 (3)
- (-) 1992 (2)
- (-) 1976 (2)
- 2022 (1)
- 2020 (1)
- 2017 (1)
- 2016 (2)
- 2015 (2)
- 2012 (1)
- 2010 (1)
- 2009 (1)
- 2008 (3)
- 2007 (2)
- 2006 (1)
- 2004 (2)
- 2003 (3)
- 2002 (2)
- 2001 (2)
- 1999 (3)
- 1998 (2)
- 1997 (2)
- 1994 (2)
- 1991 (1)
- 1990 (1)
- 1989 (1)
- 1988 (2)
- 1987 (1)
- 1986 (1)
- 1985 (3)
- 1983 (2)
- 1979 (5)
All Corporate Fellow summaries reflect the awardee and ORNL at the time the fellowship was awarded.
2014
2013
For outstanding scientific leadership in nuclear physics and foundational work in developing and applying nuclear density functional theory to atomic nuclei
For outstanding leadership and pioneering research in climate and the environmental sciences
2005
For research in the fields of astrophysics and supernova science.
For studies of the electronic structure of molecules, computational chemistry, and high-performance algorithms and computing.
For developments in biomedical engineering and biotechnology, micromechanical devices, and nanoscale imaging and detection.
2000
For distinguished research on the air/surface exchange of atmospheric trace gases and particles and their interactions with the Earth's biogeochemical cycles, and for pioneering developments in atmospheric sampling methodologies with special emphasis on the global mercury cycle.
1996
For pioneering research in ecosystem theory, ecological modeling, error analysis, hierarchy theory, and landscape ecology and for the development of basic applications in risk assessment and regional environmental analysis.
For development of Z-contrast microscopy, which allows the direct imaging of materials at the atomic scale.
For distinguished research in the field of risk assessment, including pharmacokinetic and pharmacodynamic models, interspecies extrapolation, and human exposure to dioxin and other background contaminants, and for significant contributions to environmental policy through pioneering investigations of the effectiveness of remediation technologies and through service on national and international advisory panels and boards